The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The aim of clinical study is to assess effectiveness of Bone UltraSonic Scanner (BUSS) versus densitometry (DXA) in osteoporosis detection.
Condition or disease
Study will conduct measurements in a group of postmenopausal women and use their DXA examination data as a control. BUSS data will be able to discriminate between postmenopausal women with osteoporosis compared with no osteoporosis defined by DXA measurements.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years to 90 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Age 50-90 years
Any race or ethnicity
DXA spine and hip exam within one year
Open wounds or rashes on the testing area
Active skin infection
Recent tibia surgery
Abnormal tibia anatomy
Body Mass Index > 34.9 kg/m2
Current or previous tibial fracture on side of testing
Stroke or with total or partial paralysis with residual disability lasting more than 3 months
Current or recent (within past 6 months) use of bone-active drugs:
Estrogens or selective estrogen receptor modulator (SERM)
Therapeutic doses of fluoride (> 2mg/day)
Teriparatide used currently or within past 3 months